Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Serum Interleukin 6 Levels May Predict Presentation of IgG4-Related Disease

  |  

When the researchers evaluated the ability of serum IL-6 to predict relapse, they found—unlike serum IgG4, which can be used to predict IgG4-RD relapse—no significant differences in the median observation periods and IL-6 levels between relapse and non-relapse groups.

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Tsukuda S, Ikeura T, Ito T, et al. Clinical implications of elevated serum interleukin-6 in IgG4-related disease. PLoS One. 2020 Jan 17;15(1):e0227479. eCollection 2020.

Related Articles
    IgG4-Related Kidney Disease: Diagnostics, Manifestations, & More

    IgG4-Related Kidney Disease: Diagnostics, Manifestations & More

    Immunoglobin G4-related disease (IgG4-RD) is a rare fibro-inflammatory disease of unknown etiology that has been recently recognized. It can cause fibro-inflammatory masses in almost every organ of the body and is associated with dense lymphoplasmacytic infiltration of IgG4-postitive plasma cells, storiform fibrosis and elevated levels of serum IgG4.1 IgG4-RD is a systemic disease that may…

    Case Report: Sarcoidosis in Patient with History of IgG4-Related Disease

    Sarcoidosis and IgG4-related disease (IgG4-RD) are both immune-mediated, often multi-organ, diseases of uncertain etiology capable of presenting with diverse clinical manifestations. Many clinical features are common to both conditions, including hypergammaglobulinemia, the ability to form inflammatory masses and involvement of the lymph nodes, lacrimal glands, salivary glands, meninges and lungs. Although imaging modalities, such as…

    JNT Visual / shutterstock.com

    ACR/EULAR Release New Classification Criteria for IgG4-Related Disease

    Immunoglobulin G4-related disease (IgG4-RD) can cause fibroinflammatory lesions in nearly any organ, and diagnosis is challenging. ACR/EULAR classification criteria for IgG4-RD have been developed and validated in a large cohort of patients. These criteria have performed well in tests and should contribute substantially to future clinical, epidemiologic and basic science investigations.